These strategies include: (1) surface modification of CSCs marker ligands, such as CD44 antibodies or hyaluronic acid, to achieve active targeting; (2) loading CSCs inhibitors, such as Salinomycin, in combination with Sonosensitizers; (3) utilizing the EPR effect of nanoscale systems to penetrate tumor masses (42). This evidence concerns the gene CD44 and neoplasm.